Isoacteoside (Compound)

Go to Compound classification

ID	2469
Name	Isoacteoside
Synonyms	Isoverbascoside
Structure	MOL SDF PDB SMILES InChI Structure for EE002469 (Isoacteoside) 3D Structure for EE002469 (Isoacteoside) Mrv0541 05061312202D 44 47 0 0 0 0 999 V2000 -7.8592 -11.1375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.4289 -4.9500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -5.7158 -12.3750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.1434 -6.1875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.4289 -4.1250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -6.4302 -12.7875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.8579 -6.6000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -4.2868 -12.3750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -4.2868 -11.5500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.8579 -4.9500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -5.0013 -13.6125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.5724 -8.6625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -7.8592 -10.3125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.1434 -5.3625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -5.0013 -12.7875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.1434 -3.7125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -6.4302 -13.6125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.8579 -4.1250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -5.7158 -14.0250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -4.2868 -9.0750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.8579 -7.4250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -8.5737 -9.9000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -5.0013 -8.6625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -8.5737 -9.0750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -7.8592 -8.6625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -5.7158 -9.9000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -5.7158 -9.0750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -5.0013 -10.3125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -7.1447 -9.0750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.1434 -2.8875 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -7.1447 -14.0250 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -3.5724 -3.7125 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -5.7158 -14.8500 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -2.1434 -7.8375 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -9.2881 -10.3125 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -5.0013 -7.8375 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -9.2881 -8.6625 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -7.8592 -7.8375 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -6.4302 -10.3125 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -5.0013 -11.1375 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -3.5724 -7.8375 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -7.1447 -9.9000 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -4.2868 -9.9000 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -6.4302 -8.6625 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 5 2 2 0 0 0 0 6 3 2 0 0 0 0 7 4 2 0 0 0 0 9 8 1 0 0 0 0 13 1 1 0 0 0 0 14 2 1 0 0 0 0 14 4 1 0 0 0 0 14 10 2 0 0 0 0 15 3 1 0 0 0 0 15 8 1 0 0 0 0 15 11 2 0 0 0 0 16 5 1 0 0 0 0 17 6 1 0 0 0 0 18 10 1 0 0 0 0 18 16 2 0 0 0 0 19 11 1 0 0 0 0 19 17 2 0 0 0 0 20 12 1 0 0 0 0 21 7 1 0 0 0 0 22 13 1 0 0 0 0 23 20 1 0 0 0 0 24 22 1 0 0 0 0 25 24 1 0 0 0 0 27 23 1 0 0 0 0 27 26 1 0 0 0 0 28 26 1 0 0 0 0 29 25 1 0 0 0 0 30 16 1 0 0 0 0 31 17 1 0 0 0 0 32 18 1 0 0 0 0 33 19 1 0 0 0 0 34 21 2 0 0 0 0 35 22 1 0 0 0 0 36 23 1 0 0 0 0 37 24 1 0 0 0 0 38 25 1 0 0 0 0 39 26 1 0 0 0 0 40 9 1 0 0 0 0 40 28 1 0 0 0 0 41 12 1 0 0 0 0 41 21 1 0 0 0 0 42 13 1 0 0 0 0 42 29 1 0 0 0 0 43 20 1 0 0 0 0 43 28 1 0 0 0 0 44 27 1 0 0 0 0 44 29 1 0 0 0 0 M END > <DATABASE_ID> EE002469 > <DATABASE_NAME> ExposomeExplorer > <SMILES> CC1OC(OC2C(O)C(COC(=O)\C=C\C3=CC(O)=C(O)C=C3)OC(OCCC3=CC(O)=C(O)C=C3)C2O)C(O)C(O)C1O > <INCHI_IDENTIFIER> InChI=1S/C29H36O15/c1-13-22(35)24(37)25(38)29(42-13)44-27-23(36)20(12-41-21(34)7-4-14-2-5-16(30)18(32)10-14)43-28(26(27)39)40-9-8-15-3-6-17(31)19(33)11-15/h2-7,10-11,13,20,22-33,35-39H,8-9,12H2,1H3/b7-4+ > <INCHI_KEY> FNMHEHXNBNCPCI-QPJJXVBHSA-N > <FORMULA> C29H36O15 > <MOLECULAR_WEIGHT> 624.5871 > <EXACT_MASS> 624.205420482 > <JCHEM_ACCEPTOR_COUNT> 14 > <JCHEM_AVERAGE_POLARIZABILITY> 61.44921503393915 > <JCHEM_BIOAVAILABILITY> 0 > <JCHEM_DONOR_COUNT> 9 > <JCHEM_FORMAL_CHARGE> 0 > <JCHEM_GHOSE_FILTER> 0 > <JCHEM_IUPAC> {6-[2-(3,4-dihydroxyphenyl)ethoxy]-3,5-dihydroxy-4-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]oxan-2-yl}methyl (2E)-3-(3,4-dihydroxyphenyl)prop-2-enoate > <ALOGPS_LOGP> 1.05 > <JCHEM_LOGP> 0.8194253603333341 > <ALOGPS_LOGS> -2.84 > <JCHEM_MDDR_LIKE_RULE> 1 > <JCHEM_NUMBER_OF_RINGS> 4 > <JCHEM_PHYSIOLOGICAL_CHARGE> 0 > <JCHEM_PKA> 9.643128025881985 > <JCHEM_PKA_STRONGEST_ACIDIC> 9.010202864848798 > <JCHEM_PKA_STRONGEST_BASIC> -3.6559601056599815 > <JCHEM_POLAR_SURFACE_AREA> 245.28999999999994 > <JCHEM_REFRACTIVITY> 148.40310000000002 > <JCHEM_ROTATABLE_BOND_COUNT> 11 > <JCHEM_RULE_OF_FIVE> 0 > <ALOGPS_SOLUBILITY> 9.12e-01 g/l > <JCHEM_TRADITIONAL_IUPAC> {6-[2-(3,4-dihydroxyphenyl)ethoxy]-3,5-dihydroxy-4-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]oxan-2-yl}methyl (2E)-3-(3,4-dihydroxyphenyl)prop-2-enoate > <JCHEM_VEBER_RULE> 0 $$$$
Description
Classification	Compounds > Chemical entities > Organic compounds > Phenylpropanoids and polyketides > Cinnamic acids and derivatives > Hydroxycinnamic acids and derivatives > Coumaric acids and derivatives
CAS number	61303-13-7
PubChem ID	13889686
ChEBI ID
FooDB ID	FDB020894
HMDB ID	HMDB0041025

Chemical data

MolDBi data

IUPAC Name	{6-[2-(3,4-dihydroxyphenyl)ethoxy]-3,5-dihydroxy-4-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]oxan-2-yl}methyl (2E)-3-(3,4-dihydroxyphenyl)prop-2-enoate
Traditional IUPAC Name	{6-[2-(3,4-dihydroxyphenyl)ethoxy]-3,5-dihydroxy-4-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]oxan-2-yl}methyl (2E)-3-(3,4-dihydroxyphenyl)prop-2-enoate
Formula	C29H36O15
InChI	InChI=1S/C29H36O15/c1-13-22(35)24(37)25(38)29(42-13)44-27-23(36)20(12-41-21(34)7-4-14-2-5-16(30)18(32)10-14)43-28(26(27)39)40-9-8-15-3-6-17(31)19(33)11-15/h2-7,10-11,13,20,22-33,35-39H,8-9,12H2,1H3/b7-4+
InChI Key	FNMHEHXNBNCPCI-QPJJXVBHSA-N
Molecular weight	624.5871
Exact mass	624.205420482
SMILES	CC1OC(OC2C(O)C(COC(=O)\C=C\C3=CC(O)=C(O)C=C3)OC(OCCC3=CC(O)=C(O)C=C3)C2O)C(O)C(O)C1O

ClassyFire Taxonomy

Description	belongs to the class of organic compounds known as coumaric acids and derivatives. These are aromatic compounds containing Aromatic compounds containing a cinnamic acid moiety (or a derivative thereof) hydroxylated at the C2 (ortho-), C3 (meta-), or C4 (para-) carbon atom of the benzene ring.
Kingdom	Organic compounds
Super Class	Phenylpropanoids and polyketides
Class	Cinnamic acids and derivatives
Sub Class	Hydroxycinnamic acids and derivatives
Direct Parent	Coumaric acids and derivatives
Alternative Parents	Cinnamic acid esters O-glycosyl compounds Disaccharides Tyrosols and derivatives Styrenes Catechols 1-hydroxy-2-unsubstituted benzenoids 1-hydroxy-4-unsubstituted benzenoids Fatty acid esters Oxanes Enoate esters Secondary alcohols Polyols Oxacyclic compounds Acetals Monocarboxylic acids and derivatives Organic oxides Carbonyl compounds Hydrocarbon derivatives

Publications with Isoacteoside

ID	Title	First author	Authors	Year	Journal	Volume	Issue	Pages	PubMed ID	DOI	Study design	No. of Biomarkers	No. of Intake values	No. of Concentration values	No. of Reproducibility values	No. of Correlation values	No. of Metabolomic associations	No. of Microbiota associations	No. of Cancer associations

Biomarker data

Measurements of Isoacteoside in biospecimens

Concentration values

ID	Parent ID	Depth	Subject group	Population	Country	Cohort	Biomarker Time definition	Biospecimen	Analytical method	Biomarker	Biomarker detail	Measurement size	Detected (nb)	Detected (%)	Detected only?	Arithmethic mean	Arithmethic SD	Geometric mean	Geometric SD	Min	Min (detected)	Percentile_05	Percentile_10	Percentile_25	Median	Percentile_75	Percentile_90	Percentile_95	Max	Interquartile range	Mean 95% CI lower	Mean 95% CI upper	GMean 95% CI lower	GMean 95% CI upper	Unit	Converted arithmetic mean	Converted geometric mean	Converted median	Converted unit	Adjustment type	Adjusted on	Regressed on	Expressed as	Publication

Reproducibility values

ID	Excretion ID	Subject group	Population	Country	Cohort	Biomarker Time definition	Biospecimen	Analytical method	Biomarker	Biomarker detail	Arithmetic mean	Geometric mean	Median	Unit	Adjusted on	Reproducibility size	ICC	ICC 95% CI lower	ICC 95% CI upper	CV% WS	CV% BS	VAR WS	VAR BS	Publication

Associations of Isoacteoside with exposures

Correlation values

ID	Intake ID	Excretion ID	Subject group	Population	Country	Cohort	Intake Time definition	Intake Assessment method	Intake	Intake detail	Supplement intakes included?	Intake Arithmetic mean	Intake Geometric mean	Intake Median	Intake Unit	Intake Adjusted on	Biomarker Time definition	Biospecimen	Analytical method	Biomarker	Biomarker detail	Biomarker Arithmetic mean	Biomarker Geometric mean	Biomarker Median	Biomarker Unit	Biomarker Adjusted on	Correlation size	Correlation type	Correlation value	Correlation 95% CI lower	Correlation 95% CI upper	Correlation p-value	Significant?	Measurement adjustment	Deattenuated?	Covariates	Publication

Metabolomic associations

ID	Intake ID	Excretion ID	Subject group	Population	Country	Cohort	No. of subjects	Intake Assessment method	Intake	Intervention dose	Biospecimen	Analytical method	Biomarker	Structural identification	Feature selection	Area under curve	Sensitivity	Specificity	PLS-DA VIP	Beta coefficient	Beta coefficient p-value	ANOVA p-value	Publication

Microbiota associations

ID	Biomarker	Experimental evidence	Organism	Biospecimen	Antibiotic	Bacterial source	Substrate	Publication

Associations of Isoacteoside with cancer risk

Cancer associations

ID	Excretion ID	Subject group	Population	Country	Cohort	No. of subjects	No. of cases	No. of controls	Biospecimen	Analytical method	Biomarker	Biomarker detail	Cancer	Study design	Publication

Exposure data

Measurements of Isoacteoside exposures in populations

Intake values

ID	Parent ID	Depth	Subject group	Population	Country	Cohort	Intake Time definition	Intake assessment tool	Intake food coverage	Intake time coverage	Intake Assessment method	Intake	Intake detail	Food description	Supplement intakes included?	Measurement size	Detected (nb)	Detected (%)	Detected only?	Arithmethic mean	Arithmethic SD	Geometric mean	Geometric SD	Min	Min (detected)	Percentile_05	Percentile_10	Percentile_25	Median	Percentile_75	Percentile_90	Percentile_95	Max	Interquartile range	Mean 95% CI lower	Mean 95% CI upper	GMean 95% CI lower	GMean 95% CI upper	Unit	Converted arithmetic mean	Converted geometric mean	Converted median	Converted unit	Adjustment type	Adjusted on	Regressed on	Expressed as	Publication

Associations of Isoacteoside exposures with biomarkers

Correlation values

ID	Intake ID	Excretion ID	Subject group	Population	Country	Cohort	Intake Time definition	Intake Assessment method	Intake	Intake detail	Supplement intakes included?	Intake Arithmetic mean	Intake Geometric mean	Intake Median	Intake Unit	Intake Adjusted on	Biomarker Time definition	Biospecimen	Analytical method	Biomarker	Biomarker detail	Biomarker Arithmetic mean	Biomarker Geometric mean	Biomarker Median	Biomarker Unit	Biomarker Adjusted on	Correlation size	Correlation type	Correlation value	Correlation 95% CI lower	Correlation 95% CI upper	Correlation p-value	Significant?	Measurement adjustment	Deattenuated?	Covariates	Publication